Body composition changes in treatment-experienced HIV-infected patients initiating a tenofovir-containing antiretroviral regimen

被引：0
|
作者：
Tsekes, G
Mangafas, N
Tsogas, N
Psathas, C
Vlachadami, I
Batakis, N
Lazanas, MC
机构：
[1] Red Cross Hosp, Dept Internal Med 3, Athens, Greece
[2] Red Cross Hosp, Infect Dis Unit, Athens, Greece
[3] Red Cross Hosp, Dept Radiol, Athens, Greece
来源：
ANTIVIRAL THERAPY | 2004年 / 9卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
046
引用
收藏
页码：L29 / L30
页数：2
相关论文
共 50 条
  • [21] Initiation of therapy with a subcutaneously administered antiretroviral in treatment-experienced HIV-infected patients: understanding physician and patient perspectives
    Horne, Rob
    Cooper, Vanessa
    Fisher, Martin
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2008, 20 (09): : 1029 - 1038
  • [22] The Management of Treatment-Experienced HIV-Infected Patients: New Drugs and Drug Combinations
    Wilson, Lucy E.
    Gallant, Joel E.
    CLINICAL INFECTIOUS DISEASES, 2009, 48 (02) : 214 - 221
  • [23] Effectiveness of etravirine-based therapy for treatment-experienced HIV-infected patients
    Huerta Garcia, Gloria
    Antonio Mata-Marin, Jose
    Carlos Dominguez-Hermosillo, Juan
    Chavez-Garcia, Marcelino
    Issac Banda-Lara, Marco
    Nunez-Rodriguez, Nohemi
    Enrique Cruz-Herrera, Javier
    Luis Sandoval-Ramirez, Jorge
    Villagomez-Ruiz, Alfredo
    Manjarrez-Tellez, Bulmaro
    Enrique Gaytan-Martinez, Jesus
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2016, 10 (06): : 605 - 611
  • [24] Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens
    Soler-Palacin, Pere
    Melendo, Susana
    Noguera-Julian, Antoni
    Fortuny, Claudia
    Navarro, Maria L.
    Mellado, Maria J.
    Garcia, Lourdes
    Uriona, Sonia
    Martin-Nalda, Andrea
    Figueras, Concepcio
    AIDS, 2011, 25 (02) : 171 - 176
  • [25] Body Composition and Metabolic Changes in HIV-Infected Patients
    Stanley, Takara L.
    Grinspoon, Steven K.
    JOURNAL OF INFECTIOUS DISEASES, 2012, 205 : S383 - S390
  • [26] Genotypic resistance profile in treatment-experienced HIV-infected individuals after abacavir and efavirenz salvage regimen
    Vallejo, A
    Olivera, M
    Rubio, A
    Sánchez-Quijano, A
    Lissen, E
    Leal, M
    ANTIVIRAL RESEARCH, 2004, 61 (02) : 129 - 132
  • [27] The Effect of Individual Antiretroviral Drugs on Body Composition in HIV-Infected Persons Initiating Highly Active Antiretroviral Therapy
    Shlay, Judith C.
    Sharma, Shweta
    Peng, Grace
    Gibert, Cynthia L.
    Grunfeld, Carl
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (03) : 298 - 304
  • [28] Virologic outcome of gastrostomy tube insertion in treatment-experienced pediatric HIV-infected patients
    Fung, SM
    Shliozberg, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S286 - S286
  • [29] The MOTIVATE trials: maraviroc therapy in antiretroviral treatment-experienced HIV-1-infected patients
    van Lelyveld, Steven F. L.
    Wensing, Annemarie M. J.
    Hoepelman, Andy I. M.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (11) : 1241 - 1247
  • [30] Virologic and immunologic impact and durability of enfuvirtide-based antiretroviral therapy in HIV-infected treatment-experienced patients in a clinical setting
    Loutfy, M. R.
    Antoniou, T.
    Shen, S.
    Vlaicu, M.
    Halpenny, R.
    Kovacs, C.
    Fletcher, D.
    Raboud, J. M.
    HIV CLINICAL TRIALS, 2007, 8 (01): : 36 - 44
12345